Gene · 407039
Papers2,468
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,468
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circular RNAs in diabetes mellitus and its complications. | Front Endocrinol (Lausanne) | 2022 | 35979435 | PubTator, text mining | PubMed |
| Circulating miR-148b-3p and miR-27a-3p can be potential biomarkers for diagnosis of pre-diabetes and type 2 diabetes: integrating experimental and in-silico approaches. | BMC Endocr Disord | 2022 | 35978298 | PubTator, text mining | PubMed |
| A Big Role for microRNAs in Gestational Diabetes Mellitus. | Front Endocrinol (Lausanne) | 2022 | 35957839 | PubTator, text mining | PubMed |
| Beyond Cancer: Regulation and Function of PD-L1 in Health and Immune-Related Diseases. | Int J Mol Sci | 2022 | 35955729 | PubTator, text mining | PubMed |
| Reprogrammed Lipid Metabolism and the Lipid-Associated Hallmarks of Colorectal Cancer. | Cancers (Basel) | 2022 | 35954376 | PubTator, text mining | PubMed |
| Non-Coding RNAs and Prediction of Preeclampsia in the First Trimester of Pregnancy. | Cells | 2022 | 35954272 | PubTator, text mining | PubMed |
| Research progress in toxicological effects and mechanism of aflatoxin B1 toxin. | PeerJ | 2022 | 35945939 | PubTator, text mining | PubMed |
| Noncoding RNA-mediated molecular bases of chemotherapy resistance in hepatocellular carcinoma. | Cancer Cell Int | 2022 | 35945536 | PubTator, text mining | PubMed |
| A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG/miR-193a-3p/TNFRSF21 regulatory axis in lung adenocarcinoma. | Front Oncol | 2022 | 35936736 | PubTator, text mining | PubMed |
| Potential targets and treatments affect oxidative stress in gliomas: An overview of molecular mechanisms. | Front Pharmacol | 2022 | 35935861 | PubTator, text mining | PubMed |
| The functions of long noncoding RNAs on regulation of F-box proteins in tumorigenesis and progression. | Front Oncol | 2022 | 35928868 | PubTator, text mining | PubMed |
| Identification and Validation of an m6A Modification of JAK-STAT Signaling Pathway-Related Prognostic Prediction Model in Gastric Cancer. | Front Genet | 2022 | 35928449 | PubTator, text mining | PubMed |
| Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics. | Signal Transduct Target Ther | 2022 | 35918332 | PubTator, text mining | PubMed |
| Disease-Associated Regulation of Non-Coding RNAs by Resveratrol: Molecular Insights and Therapeutic Applications. | Front Cell Dev Biol | 2022 | 35912113 | PubTator, text mining | PubMed |
| CircRNA ITCH: Insight Into Its Role and Clinical Application Prospect in Tumor and Non-Tumor Diseases. | Front Genet | 2022 | 35910224 | PubTator, text mining | PubMed |
| An integrative transcriptome analysis reveals potential predictive, prognostic biomarkers and therapeutic targets in colorectal cancer. | BMC Cancer | 2022 | 35907803 | PubTator, text mining | PubMed |
| Effects of Cyclosporine A and Adalimumab on the expression profiles histaminergic system-associated genes and microRNAs regulating these genes in HaCaT cells. | Cell Cycle | 2022 | 35899934 | PubTator, text mining | PubMed |
| Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs. | Int J Mol Sci | 2022 | 35897831 | PubTator, text mining | PubMed |
| The Role of PIM Kinases in Pediatric Solid Tumors. | Cancers (Basel) | 2022 | 35892829 | PubTator, text mining | PubMed |
| Biomaterial-Based Therapeutic Strategies for Obesity and Its Comorbidities. | Pharmaceutics | 2022 | 35890340 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407039/papers?page=23